ARGOS THERAPEUTICS INC — Form D

ARGOS THERAPEUTICS INC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2012-04-24. The offering totals $50.0M, of which $9.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
B. Jefferson ClarkDirectorDurham, NC
Monique A LaliberteDirectorMontreal, A8
Sander Jefferson van DeventerDirectorNaarden, P7
David A GryskaDirectorNew York, NY
Philip R TracyDirectorDurham, NC
Hubert D BirnerDirectorWaltham, MA
Jeffrey D AbbeyDirectorDurham, NC
Jeffrey D AbbeyExecutive OfficerDurham, NC
Andrei A PetrovDirectorMoscow, 1Z
Lori A HarrelsonExecutive OfficerDurham, NC
Charles A NicoletteExecutive OfficerDurham, NC
Frederick M MiesowiczExecutive OfficerDurham, NC
Brian R UnderdownDirectorToronto, A6
Douglas A PlessingerExecutive OfficerDurham, NC
Sander D van DeventerDirectorNaarden, P7
Jean A LamarreDirectorMontreal, A8
Michel Jefferson GrecoDirectorSte Foy Les Lyon, I0
Ines Jefferson HolzbaurDirectorMontreal, A8
Charles A. NicoletteExecutive OfficerDurham, NC
Hubert D. BirnerDirectorBoston, MA
Philip R. TracyDirectorDurham, NC
Douglas A. PlessingerExecutive OfficerDurham, NC
Brian R. UnderdownDirectorToronto, A6
Lori A. HarrelsonExecutive OfficerDurham, NC
Frederick M. MiesowiczExecutive OfficerDurham, NC

Other filings by this issuer (4)

FiledFormOfferingSold
2013-08-27D$60.0M$22.0M
2012-09-11D$16.0M$16.0M
2011-07-29D$3.5M$3.5M
2010-09-20D$6.0M$4.9M

More